InvestorsHub Logo

bas2020

02/09/23 10:36 AM

#402405 RE: Investor2014 #402400

You must be suggesting FDA "hanky panky", since they were the one requesting AUC for the small AVATAR trial...

In any event AS WITH THE AVATAR and US Rett trials, EXCELLENCE endpoints are all "Change from baseline to End of Treatment (EOT)". No AUC hanky panky!


No intent to FUD, surely...

kevindenver

02/09/23 11:22 AM

#402433 RE: Investor2014 #402400

Since both methods might be presented in a final report our exercise in understanding the difference in the endpoint calculations and their application is probably futile.
But, good to exercise the brain nonetheless.
Bullish
Bullish

Anshu2

02/09/23 5:01 PM

#402512 RE: Investor2014 #402400

What makes you so sure that CM won’t switch to AUC again? Eg, right before data release ….


In any event AS WITH THE AVATAR and US Rett trials, EXCELLENCE endpoints are all "Change from baseline to End of Treatment (EOT)". No AUC hanky panky!